Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Dec. 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 21... | December 1, 2021

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,Mercedes Carrasco ,Akebia Therapeutics Inc ,Prnewswire Akebia Therapeutics Inc ,Akebia Inducement Award Program ,Nasdaq ,Nasdaq Listing Rule ,Inducement Award Program ,Akebia Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,021 ,Akebia ,Iopharmaceutical ,Company ,Ith ,The ,Purpose ,O ,Setter ,Lives ,F ,People ,Mpacted ,Y ,Kidney ,Ranted Akba Us00972d1054 ,